Riccardo Meliconi

Riccardo Meliconi

Auto-generated profile, based on publicly available information

Riccardo Meliconi

IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in RMD Open
Verified
Journal Article
Open access
PDF file
FUFrancesco Ursini
Francesco Ursini
JCJacopo Ciaffi
Jacopo Ciaffi
LMLuana Mancarella
Luana Mancarella
LLLucia Lisi
Lucia Lisi
VBVeronica Brusi
Veronica Brusi
RMRiccardo Meliconi
Riccardo Meliconi
Objective Postacute COVID-19 syndrome (PACS) is an emerging entity characterised by a large array of manifestations, including musculoskeletal complaints, fatigue and cognitive or sleep disturbances. Since similar symptoms are present also in patients with fibromyalgia (FM), we decided to perform a web-based cross-sectional survey aimed at investigating the prevalence and predictors of FM in patients who recovered from COVID-19. Methods Data were anonymously collected between 5 and 18 April 2021. The collection form consisted of 28 questions gathering demographic information, features and duration of acute COVID-19, comorbid diseases, and other individual’s attributes such as height and weight. The American College of Rheumatology (ACR) Survey Criteria and the Italian version of the Fibromyalgia Impact Questionnaire completed the survey. Results A final sample of 616 individuals (77.4% women) filled the form 6±3 months after the COVID-19 diagnosis. Of these, 189 (30.7%) satisfied the ACR survey criteria for FM (56.6% women). A multivariate logistic regression model including demographic and clinical factors showed that male gender (OR: 9.95, 95% CI 6.02 to 16.43, p<0.0001) and obesity (OR: 41.20, 95% CI 18.00 to 98.88, p<0.0001) were the strongest predictors of being classified as having post-COVID-19 FM. Hospital admission rate was significantly higher in men (15.8% vs 9.2%, p=0.001) and obese (19.2 vs 10.8%, p=0.016) respondents. Conclusion Our data suggest that clinical features of FM are common in patients who recovered from COVID-19 and that obesity and male gender affect the risk of developing post-COVID-19 FM.

12 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EAElisa Assirelli
Elisa Assirelli
LPLia Pulsatelli
Lia Pulsatelli
PDPaolo Dolzani
Paolo Dolzani
DPDaniela Platano
Daniela Platano
EOEleonora Olivotto
Eleonora Olivotto
RMRiccardo Meliconi
Riccardo Meliconi
In osteoarthritis (OA), an inflammatory environment is responsible for the imbalance between the anabolic and catabolic activity of chondrocytes and, thus, for articular cartilage derangement. This study was aimed at providing further insight into the impairment of the anabolic cytokine IL-4 and its receptors in human OA cartilage, as well as the potential ability of IL-4 to antagonize the catabolic phenotype induced by IL-1β. The in vivo expression of IL-4 and IL-4 receptor subunits (IL-4R, IL-2Rγ, IL-13Rα1) was investigated on full thickness OA or normal knee cartilage. IL-4 expression was found to be significantly lower in OA, both in terms of the percentage of positive cells and the amount of signal per cell. IL-4 receptor type I and II were mostly expressed in mid-deep cartilage layers. No significant difference for each IL-4 receptor subunit was noted. IL-4 anti-inflammatory and anti-catabolic activity was assessed in vitro in the presence of IL-1β and/or IL-4 for 24 hours using differentiated high density primary OA chondrocyte also exhibiting the three IL-4 R subunits found in vivo. Chemokines, extracellular matrix degrading enzymes and their inhibitors were evaluated at mRNA (real time PCR) and protein (ELISA or western blot) levels. IL-4 did not affect IL-1β-induced mRNA expression of GRO-α/CXCL1, IL-8/CXCL8, ADAMTS-5, TIMP-1 or TIMP-3. Conversely, IL-4 significantly inhibited RANTES/CCL5, MIP-1α/CCL3, MIP-1β/CCL4, MMP-13 and ADAMTS-4. These results were confirmed at protein level for RANTES/CCL5 and MMP-13. Our results indicate for the first time that OA cartilage has a significantly lower expression of IL-4. Furthermore, we found differences in the spectrum of biological effects of IL-4. The findings that IL-4 has the ability to hamper the IL-1β-induced release of both MMP-13 and CCL5/RANTES, both markers of OA chondrocytes, strongly indicates IL-4 as a pivotal anabolic cytokine in cartilage whose impairment impacts on OA pathogenesis.

1 November 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
LMLuana Mancarella
Luana Mancarella
OAO. Addimanda
O. Addimanda
PPP. Pelotti
P. Pelotti
EPE. Pignotti
E. Pignotti
LPLia Pulsatelli
Lia Pulsatelli
RMR. Meliconi
R. Meliconi

14 October 2020 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
JCJacopo Ciaffi
Jacopo Ciaffi
MMMaria Francesca Morabito
Maria Francesca Morabito
PRPiero Ruscitti
Piero Ruscitti
SDSalvatore D’angelo
Salvatore D’angelo
LMLuana Mancarella
Luana Mancarella
FUFrancesco Ursini
Francesco Ursini

1 October 2003
Verified
Journal Article
Closed access
LBLuigi Boiardi
Luigi Boiardi
BCBruno Casali
Bruno Casali
DNDavide Nicoli
Davide Nicoli
EFEnrico Farnetti
Enrico Farnetti
QCQingquan Chen
Qingquan Chen
SCSalvarani Carlo
Salvarani Carlo

16 March 2005 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
TSTania Silvestri
Tania Silvestri
LPLia Pulsatelli
Lia Pulsatelli
PDPaolo Dolzani
Paolo Dolzani
LFLuigi Frizziero
Luigi Frizziero
AFAndrea Facchini
Andrea Facchini
RMRiccardo Meliconi
Riccardo Meliconi